Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,430 results that match your search.22,430 results
  • Branded and generic drugs companies could be more willing to compromise on IP rights, following the Pfizer/Ranbaxy settlement over Lipitor
  • Judges focused on whether or not to maintain the point of novelty test for determining design patent infringement in last month's hearing in Egyptian Goddess v Swisa
  • Australia: The Advisory Council on Intellectual Property (ACIP) is reviewing what constitutes patentable subject matter. ACIP has said the review will look at the appropriateness of the "method of manufacture" test as the threshold requirement for patentable subject matter and expects to circulate an issues paper in July with a request for submissions in September.
  • Attorney-client privilege is an increasingly contentious issue worldwide. Jochen Bühling and Michael Jewess introduce a series of jurisdiction-based Q&A articles
  • Because infringers sometimes cooperate, brands must do so, argue Ramesh Babu and Abhai Pandey of Lex Orbis, New Delhi
  • In the recent High Court decision of IEV International v Sadacharamani a/l Govindasamy [2008] 2 MLJ 754, the Court allowed the plaintiff's application to invalidate two of the defendant's patents.
  • In the 2007 financial act the government passed the bill called INDUSTRIA 2015 aimed at assisting innovative industrial projects for enterprises, universities, etc. Specific decrees have already been approved with respect to the first three industrial innovative projects (PIIs).
  • The Israeli Parliament (Knesset) recently amended Israel's Communications Law (Bezeq and Broadcasting) 1982 to prohibit the dissemination of email solicitations and other electronic advertisements without the recipient's prior express consent.
  • In India geographical indications are protected by sui generis legislation: the Geographical Indications of Goods (Registration & Protection) Act, 1999 [GI Act] followed by The Geographical Indications of Goods (Registration & Protection) Rules, 2002. The basis for such a model may be attributed to Article 22 of the TRIPs Agreement, which stipulates that members should provide "legal means" to prevent misuse of geographical indications.
  • Managing IP presents its second guide to the latest developments in one of Europe's most technologically dynamic and creative regions